FDA Clearance Tracker · DEN240064
CT-132
Last checked: Nov 20, 2026Latest source record: Apr 11, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Apr 11, 2025
De Novo granted
Time to decision
150 days
Received Nov 12, 2024. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Direct
Device class
Class II
The decision
- FDA number
- DEN240064
- Device name
- CT-132
- Applicant
- Click Therapeutics, Inc.
- Applicant location
- New York, NY
- Received
- Nov 12, 2024
- Decided
- Apr 11, 2025
- Decision
- De Novo granted
- Submission type
- Direct
Device type
- Device class
- Class II
- Regulation
- 21 CFR 882.5806
- Specialty
- Neurology & Neurosurgery
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for DEN240064
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Click Therapeutics, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Motivista (CT-155)510(k)
K254038 · Decided Jul 30, 2026 · 226 days after receipt
Device type: Computerized Behavioral Therapy Device For Depressive Disorders. (SAP) · Neurology & Neurosurgery
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.